General Motors Company (GM), Sanofi SA (ADR) (SNY): Ex-Lehman Hedge Fund’s Favorite Equities

Finally, at number five is Sanofi SA (ADR) (NYSE:SNY). With 3.3 million shares, Realm is the third largest holder of the French healthcare company among the 450 hedge funds we track, which is up 13% this year, recently hitting a new 52-week high of $54.48. Although Sanofi recently lost its patent protection for Eloxatin, Taxotere and Plavix, it has developed a new drug with Regeneron Pharmaceuticals Inc (NASDAQ:REGN) that could help lower cholesterol more effectively that the current statin drugs now on the market. Sanofi is also the manufacturer of Lantus, one of the most popular forms of insulin for the treatment of type-1 diabetes. Sanofi SA (ADR) (NYSE:SNY) recently announced plans to build a $75 million plant in Vietnam to address growing health care demands in Asia.

Final thoughts

Millard’s stock-picking pedigree is clearly unassailable given his reputation at Lehman.  But we are unimpressed with the performances of the top five picks and do not see a great deal of upside potential in the majority of these five positions. Most of these companies have been plagued by lackluster consumer demand and poor economic conditions. We would not be at all surprised to see many of these positions scaled back with the release of the Q1 13F filing; continue to check back at Insider Monkey for updates on the portfolio.

Disclosure: none